ISSWSH is partnering with the National Association of Nurse Practitioners in Women's Health (NPWH) for an upcoming virtual event scheduled to take place on August 16th. This event will focus on the critical topic of menopause. During this comprehensive course, participants will have the opportunity to discuss and characterize hormonal treatments, distinguishing between systemic and local applications and understanding their various prescriptions. Additionally, the webinar will cover the differences between bioidentical and non-bioidentical hormones, providing valuable insights into their unique properties and uses. This event promises to be an enriching experience for all attendees, offering in-depth knowledge and fostering a deeper understanding of menopause management. ISSWSH and NPWH members save up to $145 on the registration fee. For more information visit the NPWH website here to register!
The American Urological Association held its annual meeting recently in San Antonio, TX. ISSWSH was well-represented with many of our urology members presenting. The Sexual Medicine Society of North America kicked off its one day meeting with an interesting session on FSD, featuring Irwin Goldstein, Rachel Rubin, Alyssa Yee and Jessica Yih, moderated by Sue Goldstein. While there were only a few podium presentations on women’s sexual health, there was a course on FSD and a course on GSM, both of which promoted ISSWSH and included ISSWSH members as faculty, and two other courses that touched briefly on sexual health concerns of women--all in all, a win for our society and our field. Most importantly there was a lot of conversation among ISSWSH members and with some ISSWSH sponsors attending the conference. The AUA has been supporting FSD content for nearly two decades.
First-Ever White House Initiative on Women’s Health Research, An Effort Led by First Lady Jill Biden and the White House Gender Policy Council
The new initiative will fundamentally change how we approach and fund women’s health research.
Research on women’s health has been underfunded for decades, and many conditions that mostly or only affect women, or affect women differently, have received little to no attention. That’s why we’re announcing the launch of the first-ever White House Initiative on Women’s Health Research. If we act swiftly, we can pioneer the next generation of discoveries in women’s health – improving the lives of millions of women. The White House Initiative on Women’s Health Research will galvanize the Federal government as well as the private and philanthropic sectors to spur innovation, unleash transformative investment to close research gaps, and improve women’s health.
We have a clear goal: to fundamentally change how we approach and fund women’s health research.
First-Ever White House Initiative on Women’s Health Research, An Effort Led by First Lady Jill Biden and the White House Gender Policy Council
Read Full Statement HERE
Remarks as Prepared for Delivery by First Lady Jill Biden on a Press Call Announcing White House Initiative on Women’s Health Research
Read Full Statement HERE
We believe in our organization and believe that ISSWSH can be a key participant in The White House Initiative for Women's Health Research.
The ISSWSH Advocacy Committee along with the Board of Directors (with 195 signatures from our members) has written a letter to Dr. Mazure and the White House Initiative on Women’s Sexual Health to prioritize and allocate substantial funding towards research in women's sexual health, sexual dysfunction, and sexual pain.
See how ISSWSH is making a difference, read our letter HERE
The new initiative will fundamentally change how we approach and fund women’s health research.
Despite making up more than half of the population, women have been understudied and underrepresented in health research for far too long. Research on women’s health is drastically underfunded, leading to significant research gaps, with serious consequences for the health of women across the country. This lack of investment limits our understanding of conditions that are specific to women, predominantly affect women, or affect women differently. In order to give women and their health care providers the tools and information that they need to more effectively prevent, diagnose, and treat these conditions – from rheumatoid arthritis to menopause to Alzheimer’s disease to cardiovascular disease to endometriosis – our nation must fundamentally change how we approach and fund women’s health research.
If we act swiftly, we can pioneer the next generation of discoveries in women’s health – improving the lives of millions of women. That’s why, today, President Biden is establishing a new White House Initiative on Women’s Health Research. This new effort will be led by First Lady Jill Biden, who has long championed women’s health, and the White House Gender Policy Council. The Initiative will be chaired by Dr. Carolyn Mazure, an esteemed leader in the field of women’s health research, who will coordinate the Initiative on behalf of the Office of the First Lady and the Gender Policy Council.
Read full statement HERE
Initiated by ACOG and the AMA, this joint statement was signed by ISSWSH and 74 other organizations.
As the U.S. health care system enters a post-Roe era, we, representing dozens of major organizations of health care professionals, oppose all legislative interference in the patient–clinician relationship. Our patients need to be able to access—and our clinicians need to be able to provide—the evidence-based care that is right for them, including abortion, without arbitrary limitations, without threats, and without harm.
The wave of abortion bans going into effect in states across the country will harm patients, impair the integrity of the medical profession, and have a devastating and unquantifiable impact on the patients and clinicians it affects. People in at least half the states will now face a cruel choice between traveling hundreds of miles to receive abortion care (which is simply impossible for those who lack the resources, means, and opportunity) or being forced to continue with a pregnancy that may threaten their health, well-being, and future.
Read full statement HERE
The International Society for the Study of Women’s Sexual Health (ISSWSH) remains committed to affirming and supporting the sexual rights of all people worldwide, in accordance with the World Association for Sexual Health Declaration of Sexual Rights. As an international society, we support the WAS Declaration in its totality as it addresses sociopolitical and cultural issues related to sexual health in the various situations that may exist in different countries across the globe.
The AUA is seeking nominations to populate an upcoming guideline panel on Genitourinary Syndrome of Menopause. The AUA advocates for a diverse and inclusive environment within the association, as well as the global urology community; as such, all interested individuals are invited to apply. In an effort to create a multidisciplinary panel, applicants from multiple specialties are welcome to submit an application for this opportunity. The deadline to apply is July 8, 2022.
To apply, please visit: https://www.auanet.org/guidelines or complete and return the Nomination Form to